BridgeBio Pharma, Inc. (NASDAQ:BBIO) Q1 2026 Earnings Call Transcript May 7, 2026
BridgeBio Pharma, Inc. misses on earnings expectations. Reported EPS is $-0.84 EPS, expectations were $-0.7.
Operator: Good afternoon. I will be your conference operator today. All lines have been placed on mute to prevent any background noise. After the company’s remarks, there will be a question and answer session. And if you would like to withdraw your question, press 1 again. Thank you. Before we begin, I...
